A recent study published in Aging Cell emphasizes the serious health risks associated with severe vitamin D deficiency, characterized by serum levels below 10 nanograms per milliliter. The research, led by a team from Leumit Health Services in Israel, analyzed the health records of hundreds of thousands of individuals from Israel and the United States. Findings indicate that severe vitamin D deficiency is linked to significantly higher risks of mortality, diabetes, heart attacks, strokes, dementia, kidney failure requiring dialysis, diabetic retinopathy, and foot or toe amputations.
Read More
The study aimed to clarify whether low vitamin D levels are a direct cause of health problems or merely a marker of poor health, as individuals with illnesses tend to have lower vitamin D due to lifestyle factors. The researchers characterized vitamin D levels in the Israeli population from 2009 to 2020 and adjusted measurements to account for seasonal fluctuations, ensuring comparisons were fair across different times of the year.
They constructed two matched cohorts: one of 12,352 individuals with severe vitamin D deficiency and another with 12,352 individuals whose levels exceeded 30 nanograms per milliliter. Matching was precise across various factors, including age, sex, body mass index, and socioeconomic status. Nevertheless, the deficient group exhibited a significantly greater disease burden. For instance, the odds of foot or toe amputation were roughly four times higher in the deficient group, with increased chances of dementia, stroke, diabetic retinopathy, and heart attacks also observed.
To validate these findings, researchers compared results with data from the TriNetX network in the United States, which contains health records for over 120 million patients. After propensity score matching, they analyzed 223,175 individuals with severe deficiency and found a similar pattern of health risks.
Longitudinal follow-up over up to ten years revealed that severe deficiency predicted higher rates of adverse health outcomes. In the Israeli cohort, the adjusted hazard ratio for all-cause mortality was 2.57, with an eight-year cumulative mortality of approximately 14% in the deficient group versus 8% in controls. The US cohort reported a mortality hazard ratio of 1.59, indicating that severe deficiency consistently predicted poor health outcomes.
A significant aspect of the study involved vitamin D supplementation, determined through pharmacy dispensing records rather than self-reports. Researchers calculated how various supplements corresponded to serum vitamin D increases and found supplementation associated with reduced mortality in a dose-dependent manner. Notably, adults aged 70 and older with baseline levels below 5 nanograms per milliliter had a ten-year number needed to treat to prevent one death ranging from 9.7 to 10.5.
While the study has limitations, including the observational nature of the analysis and possible confounding factors, the convergence of evidence supports the conclusion that vitamin D status is crucial for health in aging populations. The findings suggest vitamin D could serve as a broad indicator of systemic health resilience rather than just a marker for specific diseases, proposing that immune mechanisms may play a role in these associations. Further randomized trials targeting older adults with severe deficiency are needed to confirm these benefits on a larger scale.